Comment by nextos

Look into companies doing trials with a credible track record. For example, Immunocore has good T cell receptor designs to bind common antigens in breast cancer tumors. For solid tumors, including breast cancer, the protein ID is IMC-F106C. For advanced cases, this is usually combined with a checkpoint inhibitor.